EROMONSELE IDAHOSA: Open Payments
NPI 1588659924 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$628 in 13 payments from 6 companies in 2025. Trend: 2023 $137 · 2024 $173 · 2025 $628
Food & beverage: $628
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $352 |
| Lilly USA, LLC | 4 | $177 |
| Phathom Pharmaceuticals, Inc. | 2 | $38 |
| ABBVIE INC. | 1 | $24 |
| Amgen Inc. | 1 | $19 |
| SHIELD THERAPEUTICS INC | 1 | $18 |
Products named: Ozempic, ZEPBOUND, Wegovy, MOUNJARO, VOQUEZNA, VRAYLAR, OTEZLA, ACCRUFER.
Industry payments across IN — which companies pay providers there.
